Ofatumumab – Clinical trial status

Status of clinical trials of Ofatumumab conducted by Genmab and GSK, as of late 2007. * Relapsed follicular non-Hodgkin’s lymphoma (NHL) – Phase III should report in 2009. * Rheumatoid arthritis (RA): ** Phase II – [http://clinicaltrials.

Status of clinical trials of Ofatumumab conducted by Genmab and GSK, as of late 2007.

* Relapsed follicular non-Hodgkin’s lymphoma (NHL) – Phase III should report in 2009.

* Rheumatoid arthritis (RA):

** Phase II – [http://clinicaltrials.gov/ct2/show/NCT00291928 NCT00291928] – HuMax-CD20 in patients adult RA patients who have failed one or more DMARDs

** Phase III – OFA110635/GEN410 – Ofatumumab in adult RA patients who have had an inadequate response to methotrexate

** Phase III – OFA110634/GEN411 – Ofatumumab in adult RA patients who have had an inadequate response to TNF-alpha antagonist therapy

* Diffuse large B cell lymphoma (DLBCL) – Phase II


Adapted from the Wikipedia article Ofatumumab, under the G. N. U. Free Documentation License. Please also see http://en.wikipedia.org/wiki








If you enjoyed this article, please consider sharing it!
Delicious Mixx StumbleUpon Digg

Related Articles

HepatitisEltrombopag has been studied, and shown to be effective, in two major clinical syndromes: idiopathic thrombocytopenic purpura and cirrhosis due to hep...
HepatitisEmtricitabine is indicated in combination with other antiretroviral agents for the treatment of HIV infection in adults. This indication is based on t...
HaemochromatosisMutations in the ferroportin gene are known to cause an autosomal dominant form of iron overload known as Type IV Haemochromatosis or Ferroportin Dise...
RheumatoidOfatumumab (trade name Arzerra. The drug is also known as HuMax-CD20) is a human monoclonal antibody (for the CD20 protein) which appears to inhibit e...
Arthritis TreatmentIt is the target of the monoclonal antibodies rituximab, Ibritumomab tiuxetan, and tositumomab, which are all active agents in the treatment of all B ...
Go To Top »